Tourmaline Bio, Inc. (TRML)
USD 19.87
(-9.1%)
USD 19.87
(-9.1%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -28.08 Million | -6.45 Million | -39.98 Million | -19.21 Million | -17.66 Million |
| Net Income | -42.12 Million | -19.7 Million | -47.83 Million | -22.7 Million | -18.15 Million |
| Depreciation & Amortization | 33 Thousand | 6000.00 | 623 Thousand | 447 Thousand | 379 Thousand |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 5.76 Million | 195 Thousand | - | - | - |
| Change in working capital | -168 Thousand | 902 Thousand | 2.31 Million | 1.61 Million | -85 Thousand |
| Other non-cash items | 8.94 Million | 12.14 Million | 4.83 Million | 2.22 Million | 959 Thousand |
| Investing Cash Flow | 3.84 Million | -5.06 Million | -96.38 Million | -133.3 Million | -562 Thousand |
| Investments in PPE | -56 Thousand | -5.06 Million | -2.43 Million | -1.28 Million | -562 Thousand |
| Acquisitions | - | -5 Million | - | - | - |
| Investment purchases | -16.6 Million | - | -275.87 Million | -158.23 Million | - |
| Sales/Maturities of investments | 20.5 Million | - | 181.92 Million | 26.22 Million | - |
| Other Investing Activities | 3896.00 | -5000.00 | - | - | - |
| Financing Cash Flow | 156.72 Million | 19.85 Million | 137.4 Million | 131.12 Million | 36.2 Million |
| Debt repayment | - | -150 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 70.46 Million | 20 Million | 137.67 Million | 131.12 Million | 36.2 Million |
| Other Financing Activities | -5.71 Million | 19.85 Thousand | -277 Thousand | - | - |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | -44 Thousand | 193 Thousand | 1.32 Million | 100 Thousand | - |
| Inventory | - | - | - | - | - |
| Other working capital | -124.00 | 709.00 | 992 Thousand | 1.51 Million | -85 Thousand |
| Cash at beginning of period | 8.47 Million | 150 Thousand | 17.58 Million | 38.97 Million | 20.99 Million |
| Cash at end of period | 140.95 Million | 8.47 Million | 18.61 Million | 17.58 Million | 38.97 Million |
| Capital Expenditure | -56 Thousand | -5.06 Million | -2.43 Million | -1.28 Million | -562 Thousand |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 132.47 Million | 8.32 Million | 1.02 Million | -21.38 Million | 17.98 Million |
| Free Cash Flow | -28.13 Million | -11.52 Million | -42.42 Million | -20.49 Million | -18.22 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -17.48 Million | -13.31 Million | 2.12 Million | -42.12 Million | -20.61 Million | -16.12 Million |
| Depreciation & Amortization | 10 Thousand | 10 Thousand | -1.1 Million | 33 Thousand | 1.12 Million | 7000.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.78 Million | 1388.00 | 4254.00 | 5.76 Million | 706.00 | 416.00 |
| Change in working capital | -33 Thousand | -1.81 Million | 1.7 Million | -168 Thousand | -2.45 Million | -2.7 Million |
| Other non-cash items | -927 Thousand | 35 Thousand | -1113.00 | 8.94 Million | -224.00 | 8.86 Million |
| Investing Cash Flow | -10.13 Million | -188.86 Million | -88.41 Million | 3.84 Million | 92.29 Million | -13 Thousand |
| Investments in PPE | - | - | -2.00 | -56 Thousand | -504 Thousand | -13 Thousand |
| Acquisitions | - | - | -650 Thousand | - | 650 Thousand | - |
| Investment purchases | -42.53 Million | -215.86 Million | 68.55 Million | -16.6 Million | -10.52 Million | -49.36 Million |
| Sales/Maturities of investments | 32.4 Million | 27 Million | -156.8 Million | 20.5 Million | 65.8 Million | 58.5 Million |
| Other Investing Activities | - | -188.86 Thousand | 3896.00 | 3896.00 | - | - |
| Financing Cash Flow | - | 161.35 Million | 156.46 Million | 156.72 Million | -91.94 Million | 92.2 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 5000.00 | - | - | -5000.00 |
| Common Stock Issuance | - | 161.35 Million | 91.7 Million | 70.46 Million | 74 Thousand | 142 Thousand |
| Other Financing Activities | - | 161.35 Thousand | 68.14 Thousand | -5.71 Million | -3623.00 | 92.2 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 450 Thousand | 866 Thousand | 3.58 Million | -44 Thousand | -4.42 Million | -2.21 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -483 Thousand | -2676.00 | 397.00 | -124.00 | -296.00 | -487.00 |
| Cash at beginning of period | 98.28 Million | 140.95 Million | 67.08 Million | 8.47 Million | 87.3 Million | 4.65 Million |
| Cash at end of period | 70.14 Million | 98.51 Million | 140.95 Million | 140.95 Million | 67.08 Million | 87.3 Million |
| Capital Expenditure | - | - | -2.00 | -56 Thousand | -504 Thousand | -13 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -28.13 Million | -42.44 Million | 73.87 Million | 132.47 Million | -20.22 Million | 82.64 Million |
| Free Cash Flow | -18 Million | -14.92 Million | 11.02 Million | -28.13 Million | -26.27 Million | -9.55 Million |
MBLY3
SBC
002780
LBS
KEPEN
ELI